Skip to main content

and
  1. No Access

    Article

    Effects of interleukin-3 on myelosuppression induced by chemotherapy for ovarian cancer and small cell undifferentiated tumours

    Two clinical studies were undertaken to study the toxicity profile and effects of interleukin-3 (rhIL-3) on chemotherapy-induced myelosuppression. Fifteen patients with recurrent ovarian carcinoma were treated...

    MW Dercksen, K Hoekman, WW ten Bokkel Huinink, EM Rankin in British Journal of Cancer (1993)